Disilvestro P - Search Results

1

For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?

Dizon DS, Restivo A, Lomme M, Charbonneau N, Brard L, Hughes T, Weitzen S, Legare R, Granai CO, Disilvestro P. Dizon DS, et al. Among authors: disilvestro p. Am J Clin Oncol. 2008 Feb;31(1):39-42. doi: 10.1097/COC.0b013e318134ee6f. Am J Clin Oncol. 2008. PMID: 18376226

2

Malignant mixed mesodermal tumors of the ovary.

DiSilvestro PA, Gajewski WH, Ludwig ME, Kourea H, Sung J, Granai CO. DiSilvestro PA, et al. Obstet Gynecol. 1995 Nov;86(5):780-2. doi: 10.1016/0029-7844(95)00285-Y. Obstet Gynecol. 1995. PMID: 7566848

3

'You may think I'm too old, but can't you treat my cancer?'.

DiSilvestro PA, Granai CO, Gajewski WH, Falkenberry SS. DiSilvestro PA, et al. R I Med. 1995 May;78(5):143-4. R I Med. 1995. PMID: 7606062 No abstract available.

4

Ovarian cancer? What is the next step?

Granai CO, Gajewski WH, DiSilvestro PA, Falkenberry SS. Granai CO, et al. Among authors: disilvestro pa. R I Med. 1995 May;78(5):146-8. R I Med. 1995. PMID: 7606063 Review. No abstract available.

5

Prognostic value of clinical variables in ovarian cancer.

DiSilvestro P, Peipert JF, Hogan JW, Granai CO. DiSilvestro P, et al. J Clin Epidemiol. 1997 May;50(5):501-5. doi: 10.1016/s0895-4356(97)00002-4. J Clin Epidemiol. 1997. PMID: 9180642

6

Comparison of tolerance of combination carboplatin and paclitaxel chemotherapy by age in women with ovarian cancer.

Villella JA, Chaudhry T, Pearl ML, Valea F, DiSilvestro PA, Pollack S, Chalas E. Villella JA, et al. Gynecol Oncol. 2002 Sep;86(3):316-22. doi: 10.1006/gyno.2002.6781. Gynecol Oncol. 2002. PMID: 12217754

7

Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program.

Dizon DS, Schwartz J, Rojan A, Miller J, Pires L, Disilvestro P, Gordinier ME, Moore R, Granai CO, Legare RD. Dizon DS, et al. Among authors: disilvestro p. Gynecol Oncol. 2006 Jan;100(1):149-51. doi: 10.1016/j.ygyno.2005.08.004. Epub 2005 Sep 28. Gynecol Oncol. 2006. PMID: 16197986

8

Two for good measure: six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer.

Dizon DS, Weitzen S, Rojan A, Schwartz J, Miller J, Disilvestro P, Gordinier ME, Moore R, Tejada-Berges T, Pires L, Legare R, Granai CO. Dizon DS, et al. Among authors: disilvestro p. Gynecol Oncol. 2006 Feb;100(2):417-21. doi: 10.1016/j.ygyno.2005.10.031. Epub 2005 Dec 5. Gynecol Oncol. 2006. PMID: 16336992

9

Pilot phase 2 trial of 4 months of maintenance pegylated liposomal Doxorubicin in patients with advanced ovarian cancer after complete response to platinum and Paclitaxel-based chemotherapy.

DiSilvestro PA, Fisher M, Pearl ML, Buhl A, Chalas E, Valea FA. DiSilvestro PA, et al. Gynecol Obstet Invest. 2007;63(1):1-6. doi: 10.1159/000094361. Epub 2006 Jun 30. Gynecol Obstet Invest. 2007. PMID: 16809933 Clinical Trial.

10

Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.

DiSilvestro PA, Walker JL, Morrison A, Rose PG, Homesley H, Warshal D; Gynecologic Oncology Group. DiSilvestro PA, et al. Gynecol Oncol. 2006 Dec;103(3):1038-42. doi: 10.1016/j.ygyno.2006.06.017. Epub 2006 Aug 4. Gynecol Oncol. 2006. PMID: 16889823 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters